SOURCE: Helen Moss Breast Cancer Research Foundation

April 22, 2008 08:09 ET

Ohio Doctors to See Cancer Treatment in a New Light at Conference in China

Upcoming Shanghai International Symposium Sponsored by the Society for Integrative Oncology, The University of Texas M.D. Anderson Cancer Center, and Fudan University Cancer Hospital, Shanghai; The Helen Moss Breast Cancer Research Foundation Providing Grants for Cleveland-Area Physicians to Travel to China to Explore the Integration of Traditional Chinese Medicine With Western Medicine

CLEVELAND, OH--(Marketwire - April 22, 2008) - In April, four Ohio physicians will journey to Shanghai to discover new strategies for alleviating the pain and suffering associated with cancer treatments, treating cancer as a chronic condition, and extending the lives of those afflicted, as we search for a cure. "Integrative Oncology Theory, Research, and Practice" is the theme of the Shanghai International Symposium (www.siosh.org), hosted by Fudan University Cancer Hospital in April 2008. Doctors from four distinguished hospitals in Northeast will be introduced to Traditional Chinese Medicine (TCM) and its relationship to established Western cancer treatments. They are Dr. Elizabeth McKinley, Department of Medicine, MetroHealth Medical Center (www.metrohealth.org), and Assistant Dean of Students, Case Western Reserve University School of Medicine; Dr. Cynthia Owusu, Department of Medicine, Ireland Cancer Center at University Hospitals Case Medical Center (www.uhhospitals.org/irelandcancer) and Case Western Reserve University School of Medicine; Dr. Osei-Tutu Owusu, Department of Oncology, Cleveland Clinic Foundation (www.clevelandclinic.org); Dr Jane Hart, Case Western Reserve University School of Medicine (http://casemed.case.edu).

Dr. Barrie Cassileth, a trustee of the Helen Moss Breast Cancer Research Foundation who holds the Laurance S. Rockefeller Chair of Integrative Medicine at Memorial Sloan-Kettering Cancer Center (www.mskcc.org) in New York City, will be a featured speaker at the symposium. In addition, Dr. Jane Hart and Dr. Elizabeth McKinley will present information on cancer survivorship and the role of integrative therapies that is provided to students at Case Western Reserve University School of Medicine.

Helen Moss, Managing Trustee, says: "Being diagnosed with cancer is often one of the most frightening moments in a person's life. Being treated for cancer can be a painful and debilitating ordeal. Options seem narrow for those facing this disease; however, new trends and ways of thinking are gaining ground. Traditional Chinese Medicine (TCM) has attracted attention worldwide due to its long established history, theoretical system, and clinical practice. As a result, the role of TCM and Japanese medicine in complementary and integrative medicine is increasing significantly."

Attendees of the conference will be presented with TCM practices that have been shown to improve clinical outcomes among patients with cancer, proposed mechanisms by which TCM therapies produce their effects, clinical trial results that support the use of TCM treatments in oncology practice, and evidence supporting the efficacy and safety for TCM practices.

In addition to the four Cleveland physicians, two members of the Foundation's Board of Trustees will participate in the symposium. Managing Trustee Helen Moss and Board Member Betty Ann Helms will attend along with Board Member Dr. Barrie Cassileth. Upon their return, the physicians and board members will share lessons and new strategies learned during meeting.

This initiative was made possible through grants provided by the Helen Moss Breast Cancer Research Foundation in Bratenahl, Ohio, that is dedicated to promoting new and innovative perspectives on cancer treatment and life thereafter. Managing Trustee, Helen Moss, is a metastatic breast cancer survivor who immediately dedicated herself to establishing the non-profit organization after being diagnosed in 2000. Since its inception, the Foundation has focused on prolonging life and improving its quality for those faced with cancer by incorporating nontraditional methods into mainstream medicine.

More information can be found at www.helenmoss.org.

If you'd like more information on this topic, or schedule an interview with Helen Moss, please contact Dr. Nathan Berger. Email: nathan.berger@case.edu. Phone: 216-368-4084 or 216-371-9811

Contact Information